Skip to main content
OpenTrials

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

1,388 public trials 159 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Completed

Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia

NCT00003808

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • Beckman Research Institute, City of Hope Los Angeles, California, United States
  • Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States
  • Stanford University Medical Center Stanford, California, United States
View all 71 locations
View Trial Details
Completed

Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial

NCT00897767

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +42 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
View all 214 locations
View Trial Details
Completed

Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia

NCT00003764

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • Northeast Alabama Regional Medical Center Anniston, Alabama, United States
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • MBCCOP - Gulf Coast Mobile, Alabama, United States
  • CCOP - Western Regional, Arizona Phoenix, Arizona, United States
View all 218 locations
View Trial Details
Completed

An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination With Temozolomide (TMZ) or With Carboplatin and Paclitaxel in Subjects With Advanced Solid Tumors

NCT01618136

Conditions
Adnexal Diseases, Advanced Melanoma, B-cell Malignancy, Low-grade, +37 more
Locations
  • King's College London Guy's Hospital Campus London, United Kingdom
  • Newcastle Upon Tyne NHS Foundation Trust Newcastle Upon Tyne and Wear, United Kingdom
View Trial Details
Completed

Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma

NCT00003615

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +27 more
Locations
  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • CCOP - Southern Nevada Cancer Research Foundation Las Vegas, Nevada, United States
  • Trinitas Hospital - Jersey Street Campus Elizabeth, New Jersey, United States
View Trial Details
Completed

A Study of ABT-263 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

NCT00481091

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Moores Cancer Center at UC San Diego /ID# 5566 La Jolla, California, United States
  • Dana-Farber Cancer Institute /ID# 5547 Boston, Massachusetts, United States
  • University of Nebraska Medical Center /ID# 12261 Omaha, Nebraska, United States
  • North Shore University Hospital /ID# 12267 New Hyde Park, New York, United States
View Trial Details
Completed

A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

NCT01682616

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Moores Cancer Center at UC San Diego /ID# 70398 La Jolla, California, United States
  • Northwestern University Feinberg School of Medicine /ID# 71593 Chicago, Illinois, United States
  • North Shore University Hospital /ID# 71813 New Hyde Park, New York, United States
  • Duke Cancer Center /ID# 71393 Durham, North Carolina, United States
View Trial Details

Related conditions